Hamza, Suzan A., et al. “The Rate Of Disease Progression In MS Patients Treated With Rituximab And Ocrelizumab: A Comparative Study”. INTERNATIONAL JOURNAL OF ADVANCES IN SIGNAL AND IMAGE SCIENCES, Feb. 2026, pp. 335-4, https://doi.org/10.29284/x4mwhb26.